In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Lyme Disease Tests are carried out to diagnose infections caused by the tick-borne bacterium Borrelia, which can result in neurological and joint disease. GlobalData uses proprietary data and analytics to provide a comprehensive report on the lyme disease tests devices market, including market shares of different players within Poland. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the lyme disease tests market in Poland was Meridian Bioscience followed by PerkinElmer, bioMerieux, Thermo Fisher Scientific, Bio-Rad Laboratories, DiaSorin, ERBA Diagnostics, Quidelortho and ZEUS Scientific.
This segment includes Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Western Blot Tests, and Lyme Disease Other Tests.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the lyme disease tests devices market within Poland was expected to be over $0.1m in 2022.
For the latest complete market share analysis of lyme disease tests device market in Poland, buy the report here.